Posterior reversible encephalopathy syndrome was described in 1996 as a clinical-neuroimaging entity characterized by parietooccipital watershed-region edema without overt infarction. It has been linked to hypertension, eclampsia, immunosuppressive therapies, infections, and autoimmune disorders. The condition usually has an acute onset, presents with seizures, and ameliorates within days. There have been few neuropathological studies, but in some cases, tissue damage may be more permanent.
INTRODUCTION
Posterior reversible encephalopathy syndrome (PRES), also known as reversible posterior leukoencephalopathy syndrome, hyperperfusion encephalopathy, or brain capillary leak syndrome (1), was first described in 1996 under the name "reversible posterior leukoencephalopathy" (2) . Relatively stereotypic neuroimaging findings of extensive, bilateral, white matter abnormalities in the posterior regions of the cerebral hemispheres had been recognized in 15 patients who had presented with headaches, vomiting, confusion, seizures, cortical blindness, and/or motor signs. About half were receiving immunosuppressive therapy, 12 had abrupt increases in blood pressure, and 8 had some impairment of renal function. Neuroimaging features were interpreted as "characteristic of subcortical edema without infarction" (2) . These patients with PRES were treated with antihypertensive medications and any immunosuppressive therapy was withdrawn, or the dose was reduced. In all 15 patients, the neurologic deficits resolved within 2 weeks.
Since that time, it has become clear that not all cases are clinically reversible (3) and while usually monophasic, rarely recurrence can be seen in PRES (4) . One feature from the original description that has stayed constant is the types of risk factors associated with development of PRES, including hypertension (5), preeclampsia, renal failure, autoimmune disorders, immunosuppression, malignancy, sepsis (6) , transplantation (7, 8) , and receipt of chemotherapeutic medications (9) . Thus, a heightened index of suspicion can be raised in certain patient populations. Examples of the more common medications associated with development of PRES include cyclosporine, tacrolimus, sirolimus, bevacizumab, sunitinib, and sorafenib (10) . It has been noted that some of these conditions, such as pre-eclampsia, acute hypertension, and renal failure, all share the ability to produce sudden, severe elevations in blood pressure (5) .
The mechanism underlying the development of PRES is unclear, but is postulated to be caused by hypertension exceeding the upper limit of cerebral blood flow autoregulation. If the rise in blood pressure is abrupt, the blood-brain barrier can break down, leading to extravasation of plasma and macromolecules. This is supported by the fact that treatment of hypertension often results in clinical-neuroimaging resolution (10) . In addition, endothelial dysfunction due to excess circulating cytokines may play a role, explaining the link with sepsis and other systemic disorders (10) .
The original report had noted that "changes often involved other cerebral areas, the brainstem, or the cerebellum" (2) , but a large 2007 neuroimaging study of 111 cases detailed the wide range of anatomical sites that could be involved by PRES, including parietooccipital (98.7%), posterior frontal (78.9%), temporal (68.4%), thalamic (30.3%), cerebellar (34.5%), brainstem (19.4%), and basal ganglia (11.8%) areas; even unilateral involvement (2.6%) was identified in a few cases (11) . In addition, enhancement (37.7%) and hemorrhage (17.1%) were identified in some examples (11) . Indeed, numerous large clinical and neuroimaging studies have emerged since the original description, ranging in size from 19 to 151 patients (10) . Thus, PRES is not rare and the pathologist must be cognizant of the diagnostically challenging features of PRES on both a clinical and neuroimaging basis and be able to provide histopathological confirmation if such a case comes to biopsy or autopsy.
Given the fact that mortality is 3%-6% (10), it is not surprising that the numbers of studies in the literature with histological correlation are quite limited. Those that are autopsies often represent one end of the disease spectrum and those that are biopsies may not be fully representative of all the features of PRES (5) . Histological features of PRES have been reported in 12 reports, all of which are individual cases. Changes in biopsied cases range from no histological abnor-malities (12) , to mildly edematous white matter (8) or mild vacuolization of white matter (13) , to fibrinoid vascular necrosis (5), to endothelial activation and expression of vascular endothelial growth factor (7) . Autopsy cases have shown diffuse rarefaction of white matter, perivascular T-lymphocytes, focal perivascular hemosiderin, and gliosis (3); pale myelin, swollen vascular endothelium, leakage of plasma components, and red blood cells (9) ; and endothelial prominence, vascular wall thickening, perivascular and foamy macrophages, and myelin pallor (14) . A few reports have identified subarachnoid (1) or parenchymal hemorrhages (15) . Only one noted damage epicentered on the gray matter, with cortical laminar necrosis (16) . The subcortical parieto-occipital white matter is often, but not always involved (5, 7) .
In this review paper, we detail our experience with 6 patients who carried the clinical and/or neuroimaging diagnosis of PRES, 4 of which on histological examination at autopsy turned out to have "true PRES" with findings as detailed above, and 2 of which were "PRES-like" but proved on biopsy to be alternate diagnoses.
MATERIALS AND METHODS
Database searches of our pathology department and neuroradiology files were conducted from January 01, 2010 to October 23, 2017, using the words "posterior reversible encephalopathy," "posterior reversible leukoencephalopathy," and "PRES." The authors' (B.K.D., J.M.H.) personal files were also utilized. The pathology department files queried surgical, consultation surgical, and autopsy databases. All studies were conducted in compliance with local and federal research protection guidelines. Only cases with both neuroimaging studies and histological specimens for correlation were included in the study; this resulted in exclusion of 1 consultation case sent for histological examination by an outside institution, from which the neuroimaging studies could not be retrieved. Clinical information was extracted from the medical record, with attention directed towards underlying conditions, medications received, history of chronic hypertension, and where recorded, actual blood pressure levels during the hospitalization time period antecedent to diagnosis of PRES. Time of clinical and/or neuroimaging diagnosis of PRES to time of biopsy or death was noted. All neuroimaging studies were rereviewed by the neuroradiologist on this study (J.M.H.).
For autopsied cases, both photographic images taken of the brains at the time of the initial examination and the gross brain tissues retained in formalin in our teaching collection were restudied for the purposes of this review. From the formalin-fixed tissues, additional tissue blocks were submitted on each case from bilateral parieto-occipital and frontal white matter as well as extensive cerebral and cerebellar cortical and subcortical sections, along with deep gray matter structures. In each case, a minimum of 6 cerebral subcortical white matter sections (2 each from posterior frontal and parieto-occipital regions bilaterally) and 2 cerebellar white matter sections were submitted for tissue examination. All cases had at least 2 deep white matter sections assessed identically by a battery of histochemical and immunohistochemical stains (detailed below).
Tissues were fixed in 10% buffered formalin and embedded in paraffin wax. Paraffin blocks were cut at 4 mm. Hematoxylin and eosin (H&E) sections were mounted on charged slides (Superfrost plus side, Fisher Scientific, Pittsburgh, PA), while immunohistochemical and special stains were mounted on charged slides (TOMO, Matsunami Glass Ind., Ltd., Bellingham, WA). For the purposes of this study, at least 2 deep white matter sections from each case were uniformly stained for CD68 ( All cases had been originally examined and signed out by a board-certified neuropathologist but for the purposes of this study, all were reviewed again independently by the 2 pathologists on the study (N.W., B.K.D.) with attention directed towards presence or absence of gray matter ischemic changes, laminar necrosis, hemorrhages, fibrinoid vascular necrosis and fibrin extravasation, endothelial cell prominence, intravascular thrombi, perivascular lymphocytes and hemosiderin, myelin pallor versus breakdown, astrocytosis, and microgliosis. If the patient had an underlying neoplastic disorder, the presence or absence of it in this brain was also noted.
Literature in which histological features of PRES had been detailed was reviewed. Underlying conditions, blood pressure (where recorded), medications received, and any description of gross and microscopic features in the biopsy/ autopsy report were noted.
RESULTS
Search results from our files generated 6 patients with prebiopsy/premortem clinical and/or neuroimaging diagnosis of PRES or probable PRES and correlative histology. One of the 6 patients had only had computerized tomographic (CT) scans performed premortem; the remainder had magnetic resonance imaging (MRI) studies, with multiple sequences on all 5. Only one case carried the clinical but not neuroimaging diagnosis of PRES (neuroimaging was normal); this case demonstrated classic PRES findings at autopsy (Case 2), detailed below. A seventh case, an outside biopsy consultation with clinical diagnosis of PRES, had to be excluded from the current study due to lack of available correlative neuroimaging disks.
Two of the 4 patients who had died had undergone full autopsies (Cases 1 and 3); the other 2 patients had had brainonly autopsy. One case had had spinal cord examination (Case 3). Intervals from clinical and/or neuroimaging diagnosis of PRES to demise were 11 days (Case 1), 23 days (Case 2), 17 days (Case 3), and 4 days (Case 4). The 2 cases that carried a diagnosis of PRES, but on biopsy were proved to have alternative diagnoses (Cases 5, 6), had intervals of 54 (Case 5), and 6 (Case 6) days. Thus, all cases were examined histologically at a time period days to 2.5 weeks after PRES diagnosis.
To better compare and contrast the underlying clinical risk factors and neuroimaging features of all 6 cases, the clinical and neuroimaging results are presented first, followed by descriptions and illustrations of the range of gross and histological features of these 6 cases. Cases are subdesignated below based on the eventual histological confirmatory findings to provide perspective. Features of the true PRES cases are also summarized in Table 1 .
CLINICAL AND NEUROIMAGING FEATURES OF CASES
Case 1: Classic PRES by Neuroimaging, Normal Brain at Autopsy Gross Examination, Mild PRES on Microscopical Examination
The patient was a 70-year-old woman with a history of rheumatoid arthritis, interstitial lung disease, chronic obstructive pulmonary disease, and coronary artery disease. Her medications at the time of death included prednisone, sulfasalazine, and metoprolol. She was originally admitted to hospital via the University of Colorado Hospital Emergency Department with a blood pressure of 198/62 mm Hg; however, the patient was reportedly alert, oriented, and in no acute distress. Chest X-ray revealed pneumonia, antibiotic therapy was begun, and she was admitted to rule out sepsis. One day after admission, the patient began to decline with hypoxic respiratory failure, hypotension, and acute kidney injury related to septic shock. The development of encephalopathy prompted a CT scan of the head without contrast that revealed subtle parenchymal hypoattenuation in the occipital lobes. MRI with and without gadolinium showed confluent T2 hyperintense signal in the subcortical white matter of both occipital lobes, without diffusion restriction or contrast enhancement, findings considered classic for PRES ( Fig. 1A -D). She died 35 days after admission.
Case 2: Clinical Diagnosis of PRES, Normal Neuroimaging, White Matter Petechiae on Gross Examination, Moderate PRES on Microscopical Examination
The patient was a 63-year-old man with a history of aplastic anemia who had been treated with antithymocyte globulin (ATG) and cyclosporine. He began experiencing visual hallucinations, which were clinically attributed to cyclosporine. The medication was discontinued, but with only marginal improvement of symptoms. He was admitted to the University of Colorado Hospital for treatment of pneumonia that was due to infection with Aspergillus sp. after culture documentation. Upon initial presentation, the patient was noted to have altered mental status which proceeded to decline. The differential for his encephalopathy included drug-induced (cyclosporine or amphotericin B), toxic/metabolic, infectious, PRES, and autoimmune etiologies; however, an extensive workup was negative, which included a negative MRI including negative susceptibility-weighted imaging ( Fig. 2A-D) . A trial of therapy directed toward autoimmune encephalopathy, which included 5 days of steroids and intravenous immunoglobulin, was unsuccessful. The patient declined despite all interventions and was eventually extubated and transitioned to comfort care. He succumbed 23 days after admission. The patient was a 60-year-old man with a history of coronary artery disease and acute myeloid leukemia who was Multifocal bilateral hemorrhagic and ischemic gray and white matter lesions in cerebrum and cerebellum originally admitted for a dual cord stem cell transplant following induction Clofarabine therapy. He was started on sirolimus posttransplant. The patient subsequently developed neutropenic fever for which vancomycin was initiated. During his course in the bone marrow transplant unit, he was discovered to have vancomycin resistant enterococci (Enterococcus faecium) bacteremia and an elevated HHV6 by polymerase chain reaction (blood and CSF). On hospital day 25, the patient was transferred to the medical intensive care unit because of respiratory failure and worsening encephalopathy characterized by waxing and waning delirium. This was thought to be multifactorial including HHV6 encephalitis and sirolimus-induced PRES. Neuroimaging early in the hospital course via noncontrast CT showed a small stable volume of subarachnoid blood along the left lateral occipital lobe (Fig. 3C) . Additionally, vague regions of parenchymal hypoattenuation within the deep and peripheral white matter of the posterior portions of the brain were seen with more severe findings on the left (Fig. 3A, B) . The patient developed multi-system organ failure and eventually succumbed 40 days after admission.
Case 4: Hemorrhagic PRES on Neuroimaging, Severe PRES on Gross and Microscopical Examination, With Cerebellar Involvement and Tonsillar Herniation
The patient was a 42-year-old woman who was diagnosed in March of 2009 with breast cancer after she presented with a solitary metastasis to the sternum and multiple lymph nodes. Following lumpectomy, she received 6 cycles of adjuvant TAC chemotherapy, followed by radiation to the breast and regional lymphatics, with concurrent capecitabine. PET/ CT scan showed disease progression and she failed a 3-month trial of Halotestin. She was then switched to Zoladex with exemestane when PET/CT scan showed bone progression. She also had undergone radiotherapy during this interval for multiple small metastases. Medications were then changed to Faslodex and Zoladex and eventually everolimus with exemestane. Her disease continued to progress. MRI of the brain demonstrated a solitary metastasis to the right cerebellar vermis and she underwent stereotactic radiosurgery. She received capecitabine, which was followed by disease progression in the liver and bone. Treatment regimen was then changed to Navelbine, and eventually Doxil. She received 2 cycles of low-dose Taxol, but disease continued to progress.
Eribulin therapy was initiated and eventually Palbociclib and letrozole were started. Soon after, a new 4-mm metastasis developed in the right upper occipital lobe and she had progressive symptoms including worsening dizziness and new onset of left arm symptoms. In September of 2017, MRI demonstrated multiple regions of T2/FLAIR hyperintensity in the cortical, subcortical and deep white matter in the bilateral posterior frontal, parietal, and occipital lobes, as well as the cerebellum (Fig. 4A-C) . Diffusion weighted images showed diffusion restriction consistent with infarction (Fig. 5A, B) , and gradient echo images demonstrated multifocal hemorrhages (Fig. 5C, D) . Although infarctions such as this can be seen in PRES, they are not common, and differential considerations would include multifocal embolic infarcts or intravascular lymphoma. She was discharged, but returned to the office the day after with worsening left arm numbness and then rapidly became unresponsive, prompting transferal to the hospital where she died shortly after admission.
Case 5: Clinical/Neuroimaging Diagnosis of PRES, Biopsy Diagnosis of Intravascular B-Cell Lymphoma
The patient is a 62-year-old woman who presented with sudden change in mental status originally attributed to meningoencephalitis. She was admitted to the hospital and shortly thereafter developed an abrupt change in mental status and non-verbal and uncommunicative. The patient did not carry the diagnosis of, nor have, hypertension during this admission. On MRI, axial FLAIR images showed extensive hyperintense signal in the peripheral and subcortical white matter of the posterior frontal, parietal and occipital lobes, worse on the left (Fig. 6A, B) without enhancement (Fig. 6C) , and without evidence of infarction. Imaging 2 weeks later showed new enhancement in the frontal (not pictured) and occipital lobes (Fig. 6D) . This was thought to be either acute demyelinating encephalomyelitis (ADEM) or PRES. She underwent right frontal brain biopsy, which showed intravascular B-cell lymphoma. The patient is a 58-year-old woman who originally presented with significant mental status change and progressive neurologic deficit. She had a diagnosis of hypertension that was well-controlled on lisinopril. Subsequent stereotactic biopsy showed primary CNS lymphoma of diffuse large B cell type. She underwent 5 cycles of rituximab, methotrexate, leucovorin, and vincristine (R-MPV) and 2 cycles of high dose cytarabine (Ara-C). She then completed 3 cycles of rituximab, ifosfamide, and etoposide (R-IE). Following completion of therapy, the patient developed profound encephalopathy with admission CT showing subtle parenchymal hypodensity in the occipital lobes, and regions of gliosis and volume loss in the frontal lobe and cerebellum from prior treatments. Follow-up MRI demonstrated T2/FLAIR hyperintensity in the parietal and occipital peripheral and subcortical white matter (Fig. 7A,  B) , highly reminiscent of PRES; however, post contrast images demonstrated diffuse streaking enhancement throughout the white matter (Fig. 7C) , and prominent white matter diffusion restriction (Fig. 7D ). There was a question of whether this was PRES versus diffuse spread of her primary lymphoma. Given her rapid decline, she underwent craniotomy and a second biopsy of lesion, which again showed parenchymal brain involvement by her diffuse large B-cell lymphoma but no features compatible with PRES.
NEUROPATHOLOGICAL FEATURES OF CASES Case 1
Gross autopsy brain weighed 1252 g, was devoid of herniations or subarachnoid hemorrhage, and showed only 2 equivocal petechial hemorrhages on coronal sections; white matter, including the parieto-occipital regions, was normal (Fig. 8A) . Microscopically, congestion and the small perivascular petechial hemorrhages were confirmed (Fig. 8B) , as was mild vacuolization in parieto-occipital white matter (Fig. 8C) , and diffuse microgliosis with small collections of CD68-positive macrophages (Fig. 8D) . There was subtle diffuse astrocytosis in parieto-occipital white matter. No myelin pallor or ongoing myelin breakdown was evident on LFB-PAS or MBP immunohistochemistry (IHC), and no fibrinoid vascular necrosis, fibrin extravasation, ovoid ischemic white matter lesions, neuroaxonal swellings on neurofilament protein IHC, intravascular thrombi, or cortical/subcortical ischemic damage or laminar necrosis was found. Multifocal vessels showed endothelial cell swelling in gray matter, and moderate perivascular nonneoplastic CD3-positive T cells and hemosiderin deposits were evident in white matter surrounding vessels with moderately severe hyalinization (Fig. 8C, inset) . Very mild vacuolization of cerebellar white matter was also noted. The findings were considered concordant with mild PRES, although the underlying rheumatoid arthritis may have contributed to some of the vascular changes. Systemic autopsy findings included interstitial lung disease due to rheumatoid arthritis and pulmonary vasculopathy, as well as severe contractures from rheumatoid arthritis. Cause of death was pneumonia.
Case 2
Gross autopsy brain weighed 1200 g, was devoid of herniations or subarachnoid hemorrhage, and showed only 2 small petechial hemorrhages on coronal sections; parietooccipital white matter showed petechial hemorrhages and congestion (Fig. 9A) . White matter showed multifocal vessels with fibrinoid vascular necrosis and surrounding eosinophilic fibrin extravasation (Fig. 9B) , ovoid ischemic white matter lesions associated with variable macrophage/microglial influx (Fig. 9C) , activated microglia at the perimeter of newly formed lesions with fibrinoid vascular necrosis (Fig. 9C , inset), neuroaxonal fragmentation and swelling (Fig. 9D) , and mild-moderate surrounding GFAP-positive reactive astrocytosis. All neuropathological findings were qualitatively similar to Case 2, but quantitatively greatly magnified compared with Case 2. A single identical vascular lesion with fibrinoid necrosis was found in cerebellar white matter. Mild perivascular nonneoplastic CD3-positive T cells and hemosiderin deposits were evident, seen to a lesser extent than in Case 1, but no intravascular thrombi or cortical/subcortical ischemic damage or laminar necrosis was found. The findings were considered consistent with moderate PRES. No hematopoietic neoplasm was identified in brain tissues. Autopsy was limited to the brain in this patient with underlying aplastic anemia; thus, definitive cause of death was not determined.
Case 3
Gross autopsy brain weighed 1440 g, was edematous and showed prominent uncal grooving. The left occipital pole subarachnoid hemorrhage noted premortem on imaging was <5 mL. On coronal sections, there were no petechial hemorrhages; instead the posterior frontal and especially the left parieto-occipital white matter showed tan-gray discoloration and softening without cavitation (Fig. 10A) , paralleling the CT neuroimaging findings premortem in which the left side was more affected than the right (Fig. 3A-C) . The left occipital pole showed a thin subarachnoid hemorrhage, paralleling the premortem CT scan (Fig. 3C) . Microscopically, the thin left occipital pole subarachnoid hemorrhage did not extend into cortex and both fresh blood and nearby hemosiderinladen macrophages were found in subarachnoid space. No other tissue section showed hemorrhages of any type. Striking pallor and vacuolization was evident especially in the left parieto-occipital subcortical white matter. The vacuolization and pallor could be easily appreciated on H&E (Fig. 10B) and on LFB-PAS (Fig. 10B ) more than MBP IHC. Both reactive GFAP-positive astrocytosis (Fig. 10C ) and CD68-positive macrophage influx were found throughout the damaged white matter, but maximal near the more intact U-fiber myelin at the gray-white cortical junction. Axons were fragmented and swollen throughout the damaged vacuolated white matter (Fig. 10D ), but no small ovoid, discrete, ischemic lesions associated with fibrinoid vascular necrosis were found, unlike Cases 2 and 4. Instead, broader areas of parieto-occipital white FIGURE 7. Case 6. Axial T2 (A), FLAIR (B), post contrast T1 (C), and diffusion-weighted images (D) had been performed prior to biopsy. The T2 and FLAIR images demonstrated regions of T2 hyperintensity in the posterior parietal lobes in a pattern highly reminiscent of PRES. However, the more extensive streaky subcortical contrast enhancement, and regions of mild diffuse restriction are atypical for most cases of PRES, and on re-review were considered more likely to indicate lymphoma. matter were damaged. While left parieto-occipital white matter was the most severely affected on gross examination, all sampled bilateral frontal and parieto-occipital white matter sections microscopically showed extensive vacuolization and myelin pallor at microscopic examination. Cerebellar white matter was also focally involved. The spinal cord white matter at cervical and thoracic levels manifested asymmetrical mild vacuolization in dorsal and lateral columns, sparing the lumbar regions (Fig. 10D) . The mild myelin pallor was unassociated with ongoing myelin breakdown and did not correspond to anatomical tract distribution. Axons were not fragmented or lost in these same areas on neurofilament protein IHC. The absence of correspondence to anatomical tracts, lack of axonal damage, and paucity of macrophages on CD68 suggested that this was likely mild spinal cord damage caused by PRES, rather than spinal cord Wallerian damage. In addition, no damage was seen in lumbar dorsal columns to explain any ascending tract damage in cervico-thoracic dorsal columns. No fibrinoid vascular necrosis, fibrin extravasation, intravascular thrombi or cortical/subcortical ischemic damage or laminar necrosis was found in any of the sections. Only very scant perivascular CD3-positive T cells were identified and perivascular hemosiderin was mild. There was moderately-severe vascular hyalinization of white matter vessels and a few gray matter vessels showed endothelial swelling. The findings were considered concordant with moderately severe PRES. Systemic autopsy showed no residual acute myeloid leukemia. No acute myeloid leukemia was found in brain. His cause of death was PRES, with posterior occipital edema and uncal herniation.
Case 4
Gross autopsy brain weighed 1295 g, was edematous, and multifocal petechial and larger hemorrhages were visible from the brain surface, involving bilateral occipital and superior cerebellar hemispheres. There were prominent bilateral tonsillar herniations. Careful search for venous or arterial thrombi either in the Circle of Willis or over the convexities of the brain was negative. Coronal sections showed bilateral, subcortical white matter hemorrhages involving posterior frontal lobes (Fig. 11A, B) , right parieto-occipital white matter (Fig. 11C) , and bilateral superior cerebellum (Fig. 11D) . Hemorrhages were epicentered in white matter rather than in gray matter, but in some areas extended into overlying cortex and subarachnoid space. No metastases were discerned on gross examination. Microscopically, cerebral (Fig. 12A ) and cerebellar (Fig. 12B) hemorrhages involved cortex and subarachnoid space. The white matter showed multifocal ovoid ischemic lesions associated with fibrinoid vascular necrosis and fibrin extravasation (Fig. 12C ). These were histologically identical to those seen in Case 2, but were far more numerous.
There was more GFAP-positive reactive gliosis surrounding these lesions (Fig. 11D ), more myelin damage on MBP IHC (Fig. 12E) , and more influx of CD68-positive microglia and macrophages into the ovoid areas of white matter damage (Fig. 12F) . No intravascular thrombi or vasculitis was identified. No laminar cortical necrosis was present and focal red/ dead neurons were confined to areas immediately adjacent to the large hemorrhages. Microscopic breast metastases were identified in posterior pituitary gland, left occipital lobe, and right parietal lobe, each 1-2 mm in greatest dimension. Cause of death was thought to be PRES due to uncal herniations; although no systemic autopsy had been performed at the outside hospital, her oncologist noted that her systemic metastatic breast cancer particularly involved the liver and, thus, her systemic disease may also have contributed to her death.
LITERATURE REVIEW OF PRES CASES WITH HISTOLOGICAL CORRELATION
Twelve case reports were identified in the prior literature that had corresponding histological correlation; findings extracted from these reports are summarized in Table 2 . Table 2 summarizes our literature review and helps to put the 4 true PRES cases in this report into perspective. Like autopsy reports in the literature (Table 2) , we recognize that Gross autopsy brain showed softening and discoloration in white matter, maximal in the left parieto-occipital lobe (A), although more widespread damage was found microscopically, as seen in the right occipital lobe (B) where subcortical pallor was clearly visible on H&E (whole mount), and was associated with prominent white matter vacuolization (microscopic image), myelin pallor on LFB-PAS (whole mount), and reactive astrocytosis on GFAP (whole mount). Fragmented axons were widespread in areas of white matter vacuolization (C), and spinal cord showed subtle, but asymmetrical vacuolization of dorsal and lateral columns without correspondence to anatomical tracts and with very minimal myelin pallor on LFB-PAS, as seen in the dorsal columns of the cervical cord (D) (central canal at lower right). B ¼ whole mounts H&E, LFB-PAS, GFAP, H&E microscopic, 200Â; C ¼ neurofilament immunostaining with light hematoxylin counterstain, 400Â; D ¼ LFB-PAS, 40Â.
DISCUSSION
we detail in our Cases 3 and 4, one fatal advanced end of the spectrum of PRES. However, our Case 1 was mild and the patient did not succumb to PRES. In all our 6 cases that had carried a clinical and/or neuroimaging diagnosis of PRES, the patient came to histological examination proximate to the prebiopsy/premortem diagnosis of PRES (several days to 2.5 weeks). This contrasts with the reports by Ohbu et al (17) , which followed an episode of PRES that had occurred 10-11 months prior to autopsy and the autopsy report by Jacquot et al (3) that followed 4.5 years after neuroimaging resolution of PRES. The latter report, however, was of value in that it documented that permanent damage could result from PRES, with diffuse rarefaction of white matter and scattered microinfarcts (3).
Our 4 cases of true PRES all had well-known risk factors for the disease, whereas the 2 "PRES-like" patients did not. Nevertheless, 5 of the 6 cases, including the 2 "PRESlike" cases, showed overlap in their neuroimaging features (Figs. 1 and 3-8 ; Case 2 excepted). Case 4 showed restricted diffusion, but this was found on a large recent review of clinical-neuroimaging features of PRES to be present in 15%-30% of cases (10) . Diffusion restriction has been associated with poor outcome in PRES (18) . Although our cases display some variation in anatomical distribution of lesions and absence/presence of enhancement, all except Case 2 fell well within the range of features described by McKinney et al (11) and others (10, (19) (20) (21) (22) .
Case 2, to the best of our knowledge, is the first neuropathological report to corroborate that PRES can be present histologically even when neuroimaging features of PRES are not identified-or at least had not been captured at the time that the neuroimaging study was performed. Microhemorrhages, as were identified at the time of gross and microscopical examinations in Case 2, are more likely to be observed using susceptibility-weighted neuroimaging sequences (10, 23) . However, our Case 2 did have susceptibility-weighted imaging performed prior to death and this sequence had also not shown abnormalities (Fig. 2D ). Fugate and Rabinstein observe that "PRES can also be diagnosed in the presence of normal brain imaging with the elimination of another diagnosis. We have seen patients with hypertensive encephalopathy presenting with all the clinical features of PRES, but with no acute changes on brain MRI" (10) . Case 2, despite normal MRI and susceptibility-weighted imaging, showed microscopical features very consistent with some prior reports of PRES (Table 2) .
Of our cases, Cases 1 and 3 were qualitatively similar, albeit at the 2 ends of the mild-to-severe spectrum by clinical, neuroimaging, gross and microscopic examinations. Both cases shared white matter vacuolization, microglial influx, and astrocytosis, but the myelin pallor was far more severe in subcortical white matter in Case 3 than Case 1. Similarly, Cases 2 and 4 are similar, representing the 2 ends of the spectrum of the types of PRES cases that are associated with fibrinoid vascular necrosis and fibrin extravasation. Case 4 possessed much larger numbers of ovoid ischemic white matter lesions and large bilateral supratentorial and cerebellar hemorrhages rather than the few microhemorrhages and fewer scattered ovoid white matter ischemic lesions seen in Case 2. However, Cases 2 and 4 shared the vascular injury akin to acute hypertensive injury (5, 24) , which was not identified on multiple sampled white matter sections in Cases 1 and 3. One might be tempted to speculate that Cases 2 and 4 suffered not only hypoperfusion, but subsequent hyperperfusion/elevated blood pressure levels to account for the vascular damage, but this is speculative. As noted by others, PRES has been that the "mean baseline blood pressure, the proportional rise in blood pressure, and the rapidity with which the change takes place" may affect whether damage to the blood-brain barrier occurs and edema develops (10) . An explanation offered by Kheir et al may nicely tie together the seemingly different gross and histological appearances seen in our cases, and those in the literature (Table 2) , namely some PRES cases with fibrinoid vascular necrosis, fibrin extravasation, and hemorrhages of any size, and some without. They proposed that the earliest manifestation of PRES is vasogenic edema with the correlative white matter vacuolization, with subsequent petechial hemorrhages corresponding to neuropathological findings of perivascular proteinaceous fluid and focal red cell extravasation, and then eventually worsening hemorrhage and edema representing end-stage nonreversible microvascular damage (14) . If this hypothesis is followed, then the entire process evolved quickly in our Case 4 since she had the shortest interval from clinicalneuroimaging diagnosis to death (4 days) and never fully evolved in our Case 3 despite the severity of the white matter damage.
Our Case 3 is also a unique contribution to the literature in that we show histological involvement of spinal cord. Spinal cord variant of PRES has been reported by neuroimaging (25) , but none of the reports included details of autopsy spinal cord examination.
Our Cases 3 and 4 succumbed directly to PRES, with both patients manifesting brain edema and herniations. Case 4 had hemorrhages not only in bilateral cerebral but also cerebellar sites.
While cerebellum was noted to be a possible site of (nonhemorrhagic) PRES involvement in the original report by Hinchey (2) , it was also shown by Kheir et al (14) . Indeed, our Case 4 with large hemorrhages best parallels the hemorrhagic cases of Hayashi et al and Kheir et al (9, 14) . Case 1 best parallels the report by Schiff and Lopes (13), Case 2 is most similar to the report by Decker et al (5) , and Case 3 is similar to the report by Easton (15) . However, by seeing these 4 cases collectively, rather than as single cases, we, and perhaps other neuropathologists, are better able to appreciate the challenging range of features that PRES "presents" in terms of clinical, neuroimaging, and neuropathological features. Indeed, by taking multiple bilateral subcortical cerebral and cerebellar white matter sections on each case (minimum ¼ 8), we also found subtle white matter vacuolization in cerebellar white matter, and even spinal cord that were most likely due to PRES when taken in association with findings elsewhere in brain (Case 3). Special histochemical and immunohistochemical stains on multiple white matter sections proved to be most helpful in Cases 1 and 2 where the gross findings were normal (Case 1) or subtle and easily attributed to nonspecific terminal congestion (Case 2).
It is not surprising that other conditions can come to biopsy or autopsy with the putative clinical and/or neuroimaging diagnosis of PRES. The 2 "PRES-like" patients in our study, on histological examination at biopsy, turned out to have one of the well-known numerous conditions that constitute the very wide differential diagnostic list for PRES (10) . These include infectious encephalitis, autoimmune or paraneoplastic encephalitis, malignancy (lymphoma, diffuse glioma, metastatic disease), subcortical leukoaraiosis, CNS vasculitis, progressive multifocal leukoencephalopathy, osmotic demyelination syndrome (extrapontine myelinolysis), ADEM, and toxic leukoencephalopathy (10) . The latter can be in the differential diagnostic considerations for the pathologist who encounters these often-complicated PRES-candidate patients who have received a number of different therapeutic medications prior to biopsy or autopsy. Although a detailed discussion of toxic leukoencephalopathies due to chemotherapeutic medications is beyond the scope of this review, Case 3 with more coalescent white matter damage had had a left occipital lobe subarachnoid hemorrhage premortem on neuroimaging (Fig. 3C ) and postmortem. Subarachnoid hemorrhage is the second most common type of hemorrhage seen in PRES (10) . Furthermore, at autopsy there was prominence of damage in the parieto-occipital region, the most commonly affected area in PRES, as well as in posterior frontal subcortical white matter, the second most common site affected by PRES. In addition, there was involvement of the spinal cord. Worth noting for neuropathologists, and nicely discussed by Decker et al (5) , is the histological overlap of some PRES cases with hypertensive encephalopathy.
In summary, PRES can be diagnosed by clinical features, sometimes even with normal neuroimaging studies if other conditions are excluded, can be hemorrhagic and may show enhancement in some cases. For the neuropathologist who is studying putative PRES at autopsy, it is important to remember that it involves more than just the parieto-occipital subcortical white matter, it can be a cause of death, and can even involve spinal cord. Multiple white matter sections, at a minimum from bilateral subcortical posterior fronto-parietal and parieto-occipital regions, should be taken to fully assess cases histologically for PRES at the time of autopsy. Special stains assist in the analysis especially of milder, nonfatal examples.
Potential future areas of research in PRES cases, especially optimally-fixed biopsy cases or rapid autopsies, could include investigation of connexins, cytoskeletal astroglial proteins, water channels, sodium and calcium channels, glial glutamate transporters, heat shock proteins, hypoxia-inducible transcription factors, and markers of cell death, among many other markers and pathways that can sustain astroglial dysfunction.
